Free Trial
NASDAQ:RVPHW

Reviva Pharmaceuticals (RVPHW) Stock Price, News & Analysis

Reviva Pharmaceuticals logo
$0.06 +0.00 (+3.70%)
Closing price 05/2/2025 03:49 PM Eastern
Extended Trading
$0.06 -0.01 (-9.77%)
As of 05/2/2025 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Reviva Pharmaceuticals Stock (NASDAQ:RVPHW)

Key Stats

Today's Range
$0.05
$0.06
50-Day Range
$0.03
$0.14
52-Week Range
$0.02
$0.78
Volume
12,642 shs
Average Volume
33,034 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company was founded in 2018 and is based in Cupertino, California.

Receive RVPHW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

RVPHW Stock News Headlines

Watch This Robotics Demo Before July 23rd
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."
Reviva Pharmaceuticals initiated with a Buy at Roth MKM
Reviva announces enrollment update for OLE study of brilaroxazine
Reviva Pharmaceuticals Progresses with Brilaroxazine Study Update
See More Headlines

RVPHW Stock Analysis - Frequently Asked Questions

Reviva Pharmaceuticals' stock was trading at $0.1644 on January 1st, 2025. Since then, RVPHW shares have decreased by 60.8% and is now trading at $0.0645.
View the best growth stocks for 2025 here
.

Shares of RVPHW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RVPHW
Web
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:RVPHW) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners